Daily FNArena News

Goldman Sachs has initiated coverage on McMillan Shakespeare with a Buy rating, attracted to a solid earnings growth outlook and high returns on equity.

Cochlear has recalled its Nucleus 5 device and brokers have been quick to reassess the stock given the potential impact on both earnings and reputation.

The spot uranium price was again stronger last week as traders and hedge funds moved in to take positions at low levels.

Stockbroker Moelis believes investors should have Flight Centre on their radar.

With US President Obama announcing an infrastructure and jobs plan last week Ahead of the Herd’s Rick Mills suggests investors should have infrastructure on the investment radar screen.

Market analysts at FXCM suggest a major top is being carved out for the Australian dollar against the greenback.

In the wake of the US credit rating downgrade, economists are not convinced the UK can maintain its AAA rating beyond next year.

Daily update on share prices and consensus price targets.

Investment U suggests investors look more closely at cobalt given it is a critical metal to clean energy.

A dip in gold prices at the end of last week suggests a near-term top but the technical analysts at Barclays Capital suggest buying on any move towards US$1,750 per ounce.